SVB Leerink Initiates Coverage On IDEAYA Biosciences with Outperform Rating, Announces Price Target of $33
Portfolio Pulse from richadhand@benzinga.com
SVB Leerink analyst Christopher Liu has initiated coverage on IDEAYA Biosciences (NASDAQ:IDYA) with an Outperform rating and a price target of $33.
August 08, 2023 | 1:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IDEAYA Biosciences has been given an Outperform rating and a price target of $33 by SVB Leerink.
The Outperform rating from SVB Leerink indicates that the analyst expects IDEAYA Biosciences to do better than the market average. This positive outlook, coupled with a price target of $33, suggests potential upside for the stock, which could attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100